Feasibility of measuring lipophilic or protein-bound drugs in the dermis by in vivo microdialysis after topical or systemic drug administration

Acta Dermato-Venereologica

Volumn 78, Issue 4, 1998, Pages 274-278

  Benfeldt, Eva ^a   Groth, Lotte ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b LEO PHARMA A S   (Denmark)

Author keywords

Betamethasone 17 valerate; Fusidic acid; Human; Penetration

Indexed keywords

BETAMETHASONE VALERATE; FUSIDATE SODIUM; FUSIDIC ACID;

ADULT; ANIMAL EXPERIMENT; ARTICLE; DATA ANALYSIS; DIALYSATE; DOSE RESPONSE; DRUG FORMULATION; FEMALE; FOREARM; HUMAN; HUMAN EXPERIMENT; IRRITANT DERMATITIS; LIPOPHILICITY; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT; REPRODUCIBILITY; SKIN PENETRATION; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ADULT; ANIMALS; BETAMETHASONE; CELL MEMBRANE PERMEABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; FEASIBILITY STUDIES; FEMALE; FUSIDIC ACID; HUMANS; MALE; MICRODIALYSIS; PATCH TESTS; PROTEIN SYNTHESIS INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; SENSITIVITY AND SPECIFICITY; SKIN; SKIN ABSORPTION; SODIUM DODECYL SULFATE; SURFACE-ACTIVE AGENTS;

EID: 0031870770     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/000155598441855     Document Type: Article

References (27)

1. Surber C. Drug concentration in the skin. In: Maibach HI, ed. Dermatologic research techniques. Boca Raton: CRC Press, 1996: 151-178.
2. Feldmann RJ, Maibach HI. Percutaneous penetration of steroids in man. J Invest Dermatol 1969; 52: 89-94.
3. Pershing LK, Silver BS, Krueger GG, Shah VP, Skelley JP. Feasibility of measuring the bioavailability of topical betamethasone dipropionate in commercial formulations using drug content in skin and a skin blanching bioassay. Pharmacol Res 1992; 9: 45-51.
4. Dupuis D, Rougier A, Roguet R, Lotte C, Kalopissis G. In vivo relationship between horny layer reservoir effect and percutaneous absorption in human and rat. J Invest Dermatol 1984; 82: 353-356.
5. Ungerstedt U. Measurement of neurotransmitter release by intracranial dialysis. In: Marsden CA, ed. Measurement of neurotransmitter release in vivo. Chichester: John Wiley, 1984: 81-105.
6. Scott DO, Sorensen LR, Steele KL, Puckett DL, Lunte CE. In vivo microdialysis sampling for pharmacokinetic investigations. Pharmacol Res 1991; 8: 389-392.
7. Lunte SM, Lunte CE. Microdialysis sampling for pharmacological studies: HPLC and CE analysis. Adv Chromatogr 1996; 36: 383-432.
8. Lönnroth P, Carlsten J, Johnson L, Smith U. Measurements of free tissue concentrations of propranolol. J Chromatogr 1991; 568: 419-425.
9. Ståhle L, Arner P, Ungerstedt U. Drug distribution studies with microdialysis. III: Extracellular concentration of caffeine in adipose tissue in man. Life Sci 1991; 49: 1853-1858.
10. Müller M, Schmid R, Georgopoulos A, Buxbaum A, Wasicek C, Eichler HG. Application of microdialysis to clinical pharmacokinetics in humans. Clin Pharmacol Ther 1995; 57: 371-380.
11. Müller M, Osten BV, Schmid R, Piegler E, Gerngroß, Buchegger H, Eichler HG. Theophylline kinetics in peripheral tissues in vivo in humans. Arch Pharmacol 1995; 352: 438-441.
12. Ståhle L, Alm C, Ekquist B, Lundquist B, Tomson T. Monitoring free extracellular valproic acid by microdialysis in epileptic patients. Ther Drug Monit 1996; 18: 14-18.
13. Groth L. Cutaneous microdialysis. Methodology and validation. Acta Derm Venereol (Stockh) 1996; 76: Suppl 197.
14. Church MK, Skinner SP, Burrows LJ, Bewley AP. Microdialysis in human skin (Editorial). Clin Exp Allergy 1995; 25: 1027-1029.
15. Müller M, Schmid R, Wagner O, Osten B, Shayganfar H, Eichler HG. In vivo characterisation of transdermal drug transport by microdialysis. J Control Release 1995; 37: 49-57.
16. Hegemann L, Forstinger C, Partsch B, Lagler I, Krotz S, Wolff K. Microdialysis in cutaneous pharmacology: kinetic analysis of transdermally delivered nicotine. J Invest Dermatol 1995; 104: 839-843.
17. Andersson T. Cutaneous microdialysis. A technique for human in vivo sampling. Linköping Medical Dissertations, Thesis no. 486. Linköping University, Sweden, 1995.
18. Anderson C, Andersson T, Molander M. Ethanol absorption across human skin measured by in vivo microdialysis technique. Acta Derm Venereol (Stockh) 1991; 71: 389-393.
19. Kubota K, Lo ES, Huttinot G, Andersen PH, Maibach HI. Plasma concentrations of betamethasone after topical application of betamethasone-17-valerate: comparison with oral administration. Br J Clin Pharmacol1994; 37: 86-88.
20. Moon KC, Wester RC, Maibach HI. Diseased skin models in the hairless guinea pig: in vivo percutaneous absorption. Dermatologica 1990; 180: 8-12.
21. Wilhelm KP, Surber C, Maibach HI. Effect of sodium lauryl sulphate-induced skin irritation on in vivo percutaneous penetration of four drugs. J Invest Dermatol 1991; 97: 927-932.
22. Vickers CFH. Percutaneous absorption of sodium fucidate and fusidic acid. Br J Dermatol 1969; 81: 902-908.
23. Stüttgen G, Bauer E. Penetration and permeation into human skin of fusidic acid in different galenical formulation. Arzneim-Forsch/ Drug Res 1888; 38: 730-735.
24. Vaillant L, Machet L, Taburet AM, Sørensen H, Lorette G. Levels of fusidic acid in skin blister fluid and serum after repeated administration of two dosages (250 and 500 mg). Br J Dermatol 1992; 126: 591-595.
25. Sauernheimer C, Williams KM, Brune K, Geisslinger G. Application of microdialysis to the pharmacokinetics of analgesics: problems with reduction of dialysis efficiency in vivo. J Pharmacol Toxicol Methods 1994; 32: 149-154.
26. Reeves DS. The pharmacokinetics of fusidic acid. J Antimier Chemother 1987; 20: 467-476.
27. Carneheim C, Ståhle L. Microdialysis of lipophilic compounds: a methodological study. Pharmacol Toxicol 1991; 69: 378-380.